Chapter 4. Esophageal Adenocarcinoma

  1. Janusz Jankowski MD, PhD, FRCP, FACG Consultant Gastroenterologist Fellow Professor13,14,15,16,17,
  2. Richard Sampliner MD Professor of Medicine Chief of Gastroenterology18,19,
  3. David Kerr CBE, MA, MD, DSc, FRCP, FMedSci Head of Department of Clinical Pharmacology17,20,21 and
  4. Yuman Fong MD Professor of Surgery22,23
  1. Kenneth K. Wang MD1,
  2. Vidu B. Mokkala MD2,
  3. Navtej S. Buttar MD2,
  4. Louis M. Wong Kee Song MD2,
  5. Thomas C. Smyrk MD3,
  6. Ananya Das MD, FACP, FASGE Associate Professor4,
  7. Amitabh Chak MD5,
  8. Daniela Molena MD6,
  9. Fernando Herbella MD Fellow7,
  10. Jeffrey H. Peters MD7,
  11. Aminah Jatoi MD8,
  12. Zhongxing Liao MD9,
  13. Luka Milas MD, PhD10,
  14. Ritsuko Komaki MD, FACR11,
  15. Jaffer Ajani MD9 and
  16. Herbert C. Wolfsen MD12

Published Online: 14 JAN 2009

DOI: 10.1002/9781444300147.ch4

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

How to Cite

Wang, K. K., Mokkala, V. B., Buttar, N. S., Song, L. M. W. K., Smyrk, T. C., Das, A., Chak, A., Molena, D., Herbella, F., Peters, J. H., Jatoi, A., Liao, Z., Milas, L., Komaki, R., Ajani, J. and Wolfsen, H. C. (2008) Esophageal Adenocarcinoma, in Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach (eds J. Jankowski, R. Sampliner, D. Kerr and Y. Fong), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300147.ch4

Editor Information

  1. 13

    Digestive Diseases Centre UHL Trust, Leicester, UK

  2. 14

    James Black Senior Fellow and Professor, University of Oxford, UK

  3. 15

    Cancer Research, UK

  4. 16

    Queen Mary University of London, UK

  5. 17

    Department of Clinical Pharmacology, University of Oxford, Oxford, UK

  6. 18

    University of Arizona College of Medicine, Tuscon, AZ, USA

  7. 19

    Southern Arizona VA Health Care System, USA

  8. 20

    Rhodes Professor of Cancer Therapeutics and Clinical Pharmacology, University of Oxford, UK

  9. 21

    University of Oxford, UK

  10. 22

    Murray F. Brennan Chair in Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA

  11. 23

    Weill Cornell Medical Center, New York, USA

Author Information

  1. 1

    Mayo Clinic, Department of Gastroenterology and Hepatology, Rochester, MN, USA

  2. 2

    Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, MN, USA

  3. 3

    Department of Lab medicine and Pathology, Mayo Clinic, Rochester, MN, USA

  4. 4

    Mayo Clinic Arizona, Scottsdale, AZ, USA

  5. 5

    Division of Gastroenterology, Case Western Reserve University School of Medicine, Cleveland, OH, USA

  6. 6

    Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA

  7. 7

    Department of Surgery, University of Rochester, Rochester, NY, USA

  8. 8

    Department of Oncology, Mayo Clinic, Rochester, MN, USA

  9. 9

    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

  10. 10

    Department of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

  11. 11

    Anderson Cancer Center, Houston, TX, USA

  12. 12

    Mayo Clinic College of Medicine, Rochester, MN, USA

Publication History

  1. Published Online: 14 JAN 2009
  2. Published Print: 11 APR 2008

ISBN Information

Print ISBN: 9781405127837

Online ISBN: 9781444300147

SEARCH

Keywords:

  • esophageal adenocarcinoma;
  • endoscopic diagnosis of Barrett's esophagus;
  • standard white-light endoscopy;
  • chromoendoscopy;
  • specialized intestinal metaplasia (SIM);
  • esophageal carcinoma management and radiotherapy;
  • esophageal Barrett's metaplasia prognosis;
  • light/laser-induced fluorescence spectroscopy (LIFS);
  • Optical coherence tomography (OCT)

Summary

This chapter contains sections titled:

  • Diagnosis

  • Staging of esophageal cancer

  • Treatment

  • Prognosis and follow-up

  • References